1. Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature
- Author
-
Frans M. Helmerhorst, Kluthcovsky Acgc, Sonia Afshariyamchlou, Issac Sachmechi, David A. Grimes, Nestler Je, Casey E, Bizeli R, Lokkegaard E, Chacra Apm, Gagnon C, Nanda K, Nigl F, Essah Pa, Reese M, Kai I. Cheang, C.W. Skovlund, Wickham Ep rd, Dickey Rp, Okafor E, L.H. Nielsen, O. Lidegaard, Skjeldestad Fe, Sharma S, Gallo Mf, Okamoto Jm, Laureen M Lopez, Cajoeiro Po, Dhaher Yy, Kenneth F. Schulz, Arash Ardabilygazir, Danial Mir, Schrut Gca, Chun D, Stumpf Mam, and van Vliet Ha
- Subjects
education.field_of_study ,business.industry ,Service delivery framework ,medicine.medical_treatment ,Population ,General Engineering ,030204 cardiovascular system & hematology ,Intrauterine device ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Family planning ,medicine ,Levonorgestrel ,Emergency contraception ,030212 general & internal medicine ,Medical emergency ,business ,education ,Developed country ,Reproductive health ,medicine.drug - Abstract
The Consortium has produced these medical and service delivery guidelines about oral emergency contraceptive pills to assist family planning programs and providers in assuring that the women they serve can use these regimens effectively and safely. This document reflects the latest available evidence and has been reviewed by internationally recognized reproductive health experts. Local programs are welcome to adapt these guidelines as needed to comply with national or other requirements. These guidelines do not discuss the use of the copper-bearing intrauterine device for emergency contraception. This device is the most effective emergency contraceptive option and should be offered to women when appropriate. Some of the new research and data updated include: New details on the hormone UPA and new studies on the influence of BMI on effectiveness are briefly discussed as well as how ECP regimens work their efficacy and safety guidelines on repeat use and considerations for starting or resuming regular contraceptives following ECP regimens. This update includes a Clinical Summary document (https://www.cecinfo.org/wp-content/uploads/2018/12/18-209_ICEC-Clinical-Summary_121918.pdf) which highlights essential takeaways.
- Published
- 2018
- Full Text
- View/download PDF